Methyl 2-[5-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-1,4,2,5-dioxadiazinan-2-yl]-4-methoxybutanoate
C16H19Cl2N5O5 — CID 162758238
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[5-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-1,4,2,5-dioxadiazinan-2-yl]-4-methoxybutanoate
Methyl 2-[5-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-1,4,2,5-dioxadiazinan-2-yl]-4-methoxybutanoate (PubChem CID 162758238) has the molecular formula C16H19Cl2N5O5 and a molecular weight of 432.26 g/mol. Its IUPAC name is methyl 2-[5-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-1,4,2,5-dioxadiazinan-2-yl]-4-methoxybutanoate.
Molecular Properties
| Compound Name | Methyl 2-[5-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-1,4,2,5-dioxadiazinan-2-yl]-4-methoxybutanoate |
|---|---|
| PubChem CID | 162758238 |
| Molecular Formula | C16H19Cl2N5O5 |
| Molecular Weight | 432.26 g/mol |
| Exact Mass | 431.08 |
| IUPAC Name | methyl 2-[5-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-1,4,2,5-dioxadiazinan-2-yl]-4-methoxybutanoate |
| SMILES | COCCC(C(=O)OC)N1CON(c2cc(Cl)ccc2-n2cc(Cl)nn2)CO1 |
| InChI | InChI=1S/C16H19Cl2N5O5/c1-25-6-5-13(16(24)26-2)22-9-28-23(10-27-22)14-7-11(17)3-4-12(14)21-8-15(18)19-20-21/h3-4,7-8,13H,5-6,9-10H2,1-2H3 |
| InChIKey | XTJUKLMDESONKW-UHFFFAOYSA-N |
| XLogP | 2.05 |
| TPSA | 91.18 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.26 |
| LogP ≤ 5 | 2.05 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162758238 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.